Case Report of Anti-CD123 Chimeric Antigen Receptor T-Cell Therapy Followed by Radiotherapy for a Recurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem Cell Transplantation

BACKGROUND: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematopoietic malignancy. There is no standard chemotherapy regimen for BPDCN, and even allogeneic hematopoietic stem cell transplantation (allo-HSCT) has not been able to extend the survival of patients with BPDCN. CASE REPO...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yi-li, Li, Qing, Yuan, Ting, Jiang, Yan-yu, Deng, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183776/
https://www.ncbi.nlm.nih.gov/pubmed/32368098
http://dx.doi.org/10.2147/OTT.S250016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183776/
https://www.ncbi.nlm.nih.gov/pubmed/32368098
http://dx.doi.org/10.2147/OTT.S250016

Ejemplares similares